Back to Search Start Over

The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention – results from a randomized study

Authors :
Kari Saunamäki
Anne Kaltoft
Lene Holmvang
Lene Kløvgaard
Klaus F. Kofoed
Christian Juhl Terkelsen
Thomas Engstrøm
Jens Flensted Lassen
Lars Køber
Hans Erik Bøtker
Leif Thuesen
Henning Kelbæk
Steffen Helqvist
Peter Clemmensen
Jacob Lønborg
Erik Jørgensen
Source :
Lønborg, J, Kelbæk, H, Helqvist, S, Holmvang, L, Jørgensen, E, Saunamäki, K, Kløvgaard, L, Kaltoft, A, Bøtker, H E, Lassen, J F, Thuesen, L, Terkelsen, C J, Kofoed, K F, Clemmensen, P, Køber, L & Engstrøm, T 2014, ' The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention-results from a randomized study ', European Heart Journal: Acute Cardiovascular Care . https://doi.org/10.1177/2048872614543780
Publication Year :
2014
Publisher :
Oxford University Press (OUP), 2014.

Abstract

OBJECTIVES: The impact of angiographically visible distal embolization (DE) and distal protection occurring during primary percutaneous coronary intervention (PCI) on long-term outcome has not been studied in a contemporary ST-segment elevation myocardial infarction (STEMI) cohort. To evaluate the association between DE and long-term outcome in STEMI patients treated with primary PCI with or without distal protection.METHODS AND RESULTS: In this post-hoc analysis of a randomized study, 591 STEMI patients were randomized to conventional primary PCI or primary PCI with distal protection and followed for 5 years. There was no statistically significant difference in MACE rate between patients treated with or wthout distal protection (19% versus 25%; p=0.10). There seemed to be interaction between distal protection and DE in major adverse cardiac events (MACE) (p=0.08), mortality (p=0.02) and reinfarction (p=0.06), but not admission for heart failure (p=0.40). DE was related to increased risk of admission for heart failure independently of distal protection (12.0% versus 5.0; p=0.015). The MACE rate for patients treated with standard PCI with DE was 31.3% compared to 24.8% for patients without DE (p=0.30), and 44.4% for patients treated with distal protection with DE compared to 17.9% for patients without DE (p=0.005). DE was not related to mortality (p=0.52) or reinfarction (p=0.52) among patients treated with standard PCI, but was related to higher rates of mortality (p=0.012) and reinfarction (p=0.008) when distal protection was used.CONCLUSION: DE occurred in 11% of STEMI patients treated with conventional primary PCI, and was associated with increased risk of development of heart failure. Distal protection did not improve the 5-years MACE rate, and might even aggravate the prognosis following DE, but this should only be considered hypothesis-generating.

Details

ISSN :
20488734 and 20488726
Volume :
4
Database :
OpenAIRE
Journal :
European Heart Journal: Acute Cardiovascular Care
Accession number :
edsair.doi.dedup.....10eb32befec6f00dd8916fabb4c058d5